BENEFIT OF ADD ON LOW DOSE ORAL TOLVAPTAN TO LOOP DIURETICS IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS: A RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Chitthai, Ratthaphon [1 ,2 ]
Saisa-Ard, Jingjo [1 ,2 ]
Inkong, Pitchamon [1 ,2 ]
Chaiprasert, Amnart [1 ,2 ]
Nata, Naowanit [1 ,2 ]
Tasanavipas, Pamila [1 ,2 ]
Varothai, Narittaya [1 ,2 ]
Thimachai, Paramat [1 ,2 ]
Supasyndh, Ouppatham [1 ,2 ]
Satirapoj, Bancha [1 ,2 ]
机构：
[1] Phramongkutklao Hosp & Coll Med, Div Nephrol, Dept Med, Bangkok, Thailand
[2] Phramongkutklao Hosp & Coll Med, Div Cardiol, Dept Med, Bangkok, Thailand
来源：
NEPHROLOGY | 2021年 / 26卷
关键词：
Tolvaptan; acute decompensated heart failure; ADHF score; body weight; plasma sodium;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P066
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics
    Nakamura, Makiko
    Sunagawa, Osahiko
    Kinugawa, Koichiro
    INTERNATIONAL HEART JOURNAL, 2018, 59 (01) : 87 - 93
  • [2] What Have We Learned About Loop Diuretics in Acute Decompensated Heart Failure? The DOSE Trial
    Dmitry Shchekochikhin
    JoAnn Lindenfeld
    Current Cardiology Reports, 2012, 14 : 251 - 253
  • [3] What Have We Learned About Loop Diuretics in Acute Decompensated Heart Failure? The DOSE Trial
    Shchekochikhin, Dmitry
    Lindenfeld, JoAnn
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 251 - 253
  • [4] Tolvaptan in patients with acute decompensated heart failure, could reduce renal worsening from randomized controlled trial two
    Katoh, Y.
    Hirosa, T.
    Uchida, T.
    Taniguchi, H.
    Okuda, J.
    Enomoto, S.
    Kouchi, I.
    EUROPEAN HEART JOURNAL, 2015, 36 : 668 - 668
  • [5] The prognostic implication of the diuretic and natriuretic responses to the combined administration of loop diuretics and tolvaptan in patients with acute decompensated heart failure
    Sakaguchi, T.
    Hirata, A.
    Kashiwase, K.
    Higuchi, Y.
    Yasumura, Y.
    EUROPEAN HEART JOURNAL, 2017, 38 : 506 - 506
  • [6] DURATION OF ORAL LOOP DIURETICS AND 30-DAY READMISSION IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE
    Laliberte, Benjamin
    Reed, Brent
    Devabhakthuni, Sandeep
    Watson, Kristin
    Ivaturi, Vijay
    Liu, Tao
    Gottlieb, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 671 - 671
  • [7] Metolazone Versus Chlorothiazide as Add-On Therapy to Loop Diuretics in Patients with Acute Decompensated Heart Failure and Renal Insufficiency
    Moranville, Michael
    Choi, Suji
    Hogg, Jennifer
    Rich, Jonathan D.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S84 - S84
  • [8] Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease
    Uemura, Yusuke
    Shibata, Rei
    Takemoto, Kenji
    Uchikawa, Tomohiro
    Koyasu, Masayoshi
    Ishikawa, Shinji
    Mitsuda, Takayuki
    Miura, Ayako
    Imai, Ryo
    Iwamiya, Satoshi
    Ozaki, Yuta
    Kato, Tomohiro
    Miura, Takanori
    Watarai, Masato
    Murohara, Toyoaki
    HEART AND VESSELS, 2016, 31 (10) : 1643 - 1649
  • [9] Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease
    Yusuke Uemura
    Rei Shibata
    Kenji Takemoto
    Tomohiro Uchikawa
    Masayoshi Koyasu
    Shinji Ishikawa
    Takayuki Mitsuda
    Ayako Miura
    Ryo Imai
    Satoshi Iwamiya
    Yuta Ozaki
    Tomohiro Kato
    Takanori Miura
    Masato Watarai
    Toyoaki Murohara
    Heart and Vessels, 2016, 31 : 1643 - 1649
  • [10] Effectiveness of Diuretics to Patients with Acute Decompensated Heart Failure
    Yagyu, Takeshi
    Fujino, Masashi
    Takahama, Hiroyuki
    Kanzaki, Hideaki
    Goto, Yoichi
    Kitakaze, Masafumi
    Ishihara, Masaharu
    Yasuda, Satoshi
    Ogawa, Hisao
    Yokoyama, Hiroyuki
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S171 - S171
12345